£20.94

Generic Drugs: The Pay-for-Delay Problem (Public Health in the 21st Century Series)

Price data last checked 62 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£21 today · usual range £13–£30 · best ever £13

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 29 days · 29 data points (no recent data)

Historical
Generating forecast…
£29.93 £11.54 £15.55 £19.56 £23.58 £27.59 £31.60 04 May 2026 11 May 2026 18 May 2026 25 May 2026 01 June 2026

Price Distribution

Price distribution over 29 days • 5 price levels

Days at Price
Current Price
6 days 6 days 8 days 4 days · current 5 days 0 2 4 6 8 £13 £15 £18 £21 £30 Days at Price

Price Analysis

Most common price: £18 (8 days, 27.6%)

Price range: £13 - £30

Price levels: 5 different prices over 29 days

Description

Brand-name pharmaceutical companies can delay generic competition that lowers prices by agreeing to pay a generic competitor to hold its competing product off the market for a certain period of time. These so-called "pay-for-delay" agreements have arisen as part of patent litigation settlement agreements between brand-name and generic pharmaceutical companies. "Pay-for-delay" agreements are "win-win" for the companies: brand name pharmaceutical prices stay high, and the brand and generic share the benefits of the brand's monopoly profits. Consumers lose, however: they miss out on generic prices that can be as much as 90 percent less than brand prices. For example, brand-name medication that costs $300 per month, might be sold as a generic for as little as $30 per month. This book examines the "pay-for-delay' program and how drug company pay-offs cost consumers billions.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
16 February 2011
Listed Since
27 September 2010

Barcode

No barcode data available

Similar Products You Might Like

Pharmaceutical Industry Developments: Specialty Drugs, Coupons, Reverse Payments & Product Hopping (Pharmacology - Research, Safety Testing and Regulation)
78% match

Pharmaceutical Industry Developments: Specialty Drugs, Coupons, Reverse Payments & Product Hopping (Pharmacology - Research, Safety Testing and Regulation)

£114.99 03 Jun 2026
GENERIC DRUGS: Guidelines for bioequivalence studies
77% match

GENERIC DRUGS: Guidelines for bioequivalence studies

VDM Verlag

£52.00 16 Jun 2026
Medicare Part D & Prescription Drugs (Health Care Issues, Costs and Access)
77% match

Medicare Part D & Prescription Drugs (Health Care Issues, Costs and Access)

£72.81 19 Jun 2026
Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)
77% match

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

Springer

£91.42 31 May 2026
Are Chronic Degenerative Diseases Part of the Ageing Process?: Insights from Comparative Biology
77% match

Are Chronic Degenerative Diseases Part of the Ageing Process?: Insights from Comparative Biology

Nova Science Publishers Inc

£68.58 05 Jun 2026
Competition and Marketing Strategies in the Pharmaceutical Industry (RLE Marketing) (Routledge Library Editions: Marketing)
77% match

Competition and Marketing Strategies in the Pharmaceutical Industry (RLE Marketing) (Routledge Library Editions: Marketing)

Routledge

£49.04 01 Jun 2026
Ethics and the Pharmaceutical Industry
77% match

Ethics and the Pharmaceutical Industry

Cambridge University Press

£39.68 09 Jun 2026
The 340B Drug Pricing Program (Health Care in Transition)
77% match

The 340B Drug Pricing Program (Health Care in Transition)

£172.99 15 Jun 2026
The Next Frontier for Public Health Medicines Market
77% match

The Next Frontier for Public Health Medicines Market

£55.00 30 Jun 2026
Medicare Drug Pricing Reform and Policy Challenges: Navigating Legal Frameworks, Administrative Action, and Market Effects (Health Care in Transition Series)
76% match

Medicare Drug Pricing Reform and Policy Challenges: Navigating Legal Frameworks, Administrative Action, and Market Effects (Health Care in Transition Series)

SNOVA

£150.99 30 Jul 2026
Public Economics
76% match

Public Economics

New Century Publications

£18.22 30 Jul 2026
Good Clinical Practices in Pharmaceuticals (Drugs and the Pharmaceutical Sciences)
76% match

Good Clinical Practices in Pharmaceuticals (Drugs and the Pharmaceutical Sciences)

CRC Press

£50.16 05 Jun 2026
Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)
76% match

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Routledge

£45.99 25 May 2026
Intellectual Property, Medicine and Health (Intellectual Property, Theory, Culture)
76% match

Intellectual Property, Medicine and Health (Intellectual Property, Theory, Culture)

Routledge

£43.90 05 Jun 2026
Clinical Genetics: Problems in Diagnosis and Counseling
76% match

Clinical Genetics: Problems in Diagnosis and Counseling

Academic Press

£43.99 09 Jun 2026
Preventive Health Care: Select Analyses of Cost Savings Literature, Services & Use of Examinations (Public Health in the 21st Century)
76% match

Preventive Health Care: Select Analyses of Cost Savings Literature, Services & Use of Examinations (Public Health in the 21st Century)

Nova Science Pub Inc

£69.36 13 Jul 2026
The Economics of Diseases and Cures (Economic Issues, Problems and Perspectives)
75% match

The Economics of Diseases and Cures (Economic Issues, Problems and Perspectives)

£203.99 07 Jun 2026
The Role of Gene in Cardiovascular Diseases
75% match

The Role of Gene in Cardiovascular Diseases

£41.00 30 Jun 2026
FDA's Expedited Drug Programs: Analysis, Postmarket Monitoring & Industry Guidance (Drug Transit and Distribution, Interception and Control)
75% match

FDA's Expedited Drug Programs: Analysis, Postmarket Monitoring & Industry Guidance (Drug Transit and Distribution, Interception and Control)

£82.83 30 Jun 2026
Public-Private Partnerships in Health: Improving Infrastructure and Technology
75% match

Public-Private Partnerships in Health: Improving Infrastructure and Technology

Springer

£38.63 27 May 2026
75% match

Smolen Controlled ∗drug∗ Bioavailability – Bioavailability Control By Drug Deliver: v. 3

Wiley-Blackwell

£94.50 05 Jun 2026
Community Pharmacy: An International Comparison (Public Health in the 21st Century)
75% match

Community Pharmacy: An International Comparison (Public Health in the 21st Century)

£100.99 30 Jul 2026
Managing Biotechnology: From Science to Market in the Digital Age
75% match

Managing Biotechnology: From Science to Market in the Digital Age

Wiley

£32.80 05 Jun 2026
PROPOFOL PHARMACOKINETICS MEDICAL US: Pharmacokinetics, Medical Uses & Potential Health Effects (Pharmacology-research, Safety Testing and Regulation)
75% match

PROPOFOL PHARMACOKINETICS MEDICAL US: Pharmacokinetics, Medical Uses & Potential Health Effects (Pharmacology-research, Safety Testing and Regulation)

Nova Science Publishers Inc

£57.99 09 Jun 2026